Sesamin/episesamin compositions

Details for Australian Patent Application No. 2005320579 (hide)

Owner Suntory Holdings Limited

Inventors Ono, Yoshiko; Tomimori, Namino; Rogi, Tomohiro; Tokuda, Saki

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005320579

PCT Pub. Number WO2006/070856

Priority 2004-381806 28.12.04 JP; 2004-381726 28.12.04 JP

Filing date 28 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 22 September 2011

International Classifications

A61K 31/36 (2006.01)

A23L 1/30 (2006.01) Foods or foodstuffs - containing additives

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 39/06 (2006.01) General protective or antinoxious agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/070856 Priority application(s): WO2006/070856

2 July 2009 Assignment before Grant

  Suntory Limited The application has been assigned to Suntory Holdings Limited

22 September 2011 Application Accepted

  Published as AU-B-2005320579

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005320585-Process for producing carbon-diminished aldose compound

2005320547-Method for stabilizing anti-dementia drug